Loading Purplepass...
Expectations for Products Used in Early Phase
Presented By Netzealous LLC DBA - Compliance4All
Wednesday, May 16th at 10:00am PST
Online sale ends: 05/16/18 at 9:00am PST
Online
Fremont, CA 94539
-= series =-
Buy Tickets
|
Description
Overview: This presentation will review the GMP guidance document and discuss how it may be integrated with the recommendations of the guidance documents on CMC requirements. Areas Covered in the Session: Discussion of the elements found in the guidance document for Phase 1 material What to do at really early stages What about special IND studies? What about preclinistudies? Who Will Benefit: Regulatory Affairs Personnel who Coordinate Activities for the CMC Sections of Submissions QA/QC Personnel who Need to Plan Work on Early Stage Material R & D Personnel who Will Contribute data to CMC Sections Project Managers for Product Development Studies Speaker Profile: Steven S. Kuwahara , Ph.D. is the founder and Principal of GXP BioTechnology LLC, a consulting firm that works in the areas covered by the GLP and GMP of drugs, biologics, and nutraceuticals. Event Fee: One Dial-in One Attendee Price: US$150.00 Contact Detail: Compliance4All DBA NetZealous, Phone: +1-800-447-9407 Email: support@compliance4All.com Additional Information
http://www.compliance4all.com/control/w_product/~product_id=501877LIVE?channel=purplepass_May_2018_SEO
|
Presented By
10:00am to 11:15am
General Admission: $150.00
50 18004479407 UPCOMING EVENTS
|
